Publications by authors named "Ryudai Abe"

Claim this Profile
A
Association Between PD-L1 Expression and Interstitial Lung Disease Risk in EGFR-mutant NSCLC Treated With EGFR-TKIs.
Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige

In Vivo· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige

Anticancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Response and Survival in Thyroid Transcription Factor-1 Negative Non-squamous Non-small Cell Lung Cancer.
Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige

Cancer Diagn Progn· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythrocytosis as an indicator of disease progression of small cell lung cancer: A case report.
Takuya Tanaka, Yutaka Takahara, Ryudai Abe, Nagae Sumito, Yoko Ishige

Respir Med Case Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Young-Onset, ROS1-Rearranged Adenocarcinoma of the Lung With Cardiac Tamponade: A Case Report.
Masafumi Nojiri, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yutaka Takahara

Cureus· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the Efficacy of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor in Patients With EGFR Exon 21 L858R Point Mutation-Positive Non-small Cell Lung Cancer.
Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige

Cureus· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease control in patients with non-small cell lung cancer using pemetrexed: Investigating the best treatment strategy.
Yutaka Takahara, Ryudai Abe, Nagae Sumito, Takuya Tanaka, Yoko Ishige

Thorac Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of response of patients with non-small cell lung cancer to docetaxel (plus ramucirumab) therapy in second-line treatment.
Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige

Thorac Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of response factors for monotherapy with immune checkpoint inhibitors in non-small cell lung cancer patients with PD-L1 expression <50.
Yutaka Takahara, Ryudai Abe, Nagae Sumito, Takuya Tanaka, Yoko Ishige

Thorac Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis